Logo image of ABSI

ABSCI CORP (ABSI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ABSI - US00091E1091 - Common Stock

3.56 USD
+0.04 (+1.14%)
Last: 12/24/2025, 8:12:10 PM
3.57 USD
+0.01 (+0.28%)
After Hours: 12/24/2025, 8:12:10 PM
Fundamental Rating

3

Taking everything into account, ABSI scores 3 out of 10 in our fundamental rating. ABSI was compared to 530 industry peers in the Biotechnology industry. The financial health of ABSI is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ABSI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ABSI has reported negative net income.
ABSI had a negative operating cash flow in the past year.
In the past 5 years ABSI always reported negative net income.
ABSI had a negative operating cash flow in each of the past 5 years.
ABSI Yearly Net Income VS EBIT VS OCF VS FCFABSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -46.78%, ABSI perfoms like the industry average, outperforming 53.02% of the companies in the same industry.
The Return On Equity of ABSI (-54.49%) is better than 63.77% of its industry peers.
Industry RankSector Rank
ROA -46.78%
ROE -54.49%
ROIC N/A
ROA(3y)-43.94%
ROA(5y)-42.38%
ROE(3y)-52.85%
ROE(5y)-52.12%
ROIC(3y)N/A
ROIC(5y)N/A
ABSI Yearly ROA, ROE, ROICABSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

ABSI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABSI Yearly Profit, Operating, Gross MarginsABSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K

More info and screens

5

2. Health

2.1 Basic Checks

ABSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ABSI has been increased compared to 1 year ago.
Compared to 5 years ago, ABSI has more shares outstanding
ABSI has a better debt/assets ratio than last year.
ABSI Yearly Shares OutstandingABSI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ABSI Yearly Total Debt VS Total AssetsABSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ABSI has an Altman-Z score of 4.99. This indicates that ABSI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.99, ABSI is in the better half of the industry, outperforming 72.64% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that ABSI is not too dependend on debt financing.
ABSI has a Debt to Equity ratio (0.00) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.99
ROIC/WACCN/A
WACC8.8%
ABSI Yearly LT Debt VS Equity VS FCFABSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ABSI has a Current Ratio of 5.89. This indicates that ABSI is financially healthy and has no problem in meeting its short term obligations.
ABSI has a Current ratio of 5.89. This is in the better half of the industry: ABSI outperforms 61.32% of its industry peers.
A Quick Ratio of 5.89 indicates that ABSI has no problem at all paying its short term obligations.
ABSI's Quick ratio of 5.89 is fine compared to the rest of the industry. ABSI outperforms 62.64% of its industry peers.
Industry RankSector Rank
Current Ratio 5.89
Quick Ratio 5.89
ABSI Yearly Current Assets VS Current LiabilitesABSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

ABSI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.64%.
The Revenue for ABSI has decreased by -33.09% in the past year. This is quite bad
Measured over the past years, ABSI shows a quite strong growth in Revenue. The Revenue has been growing by 17.09% on average per year.
EPS 1Y (TTM)3.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
Revenue 1Y (TTM)-33.09%
Revenue growth 3Y-1.75%
Revenue growth 5Y17.09%
Sales Q2Q%-77.78%

3.2 Future

The Earnings Per Share is expected to grow by 17.17% on average over the next years. This is quite good.
ABSI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 71.98% yearly.
EPS Next Y8.18%
EPS Next 2Y11.08%
EPS Next 3Y11.19%
EPS Next 5Y17.17%
Revenue Next Year-18.65%
Revenue Next 2Y109.16%
Revenue Next 3Y87.68%
Revenue Next 5Y71.98%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABSI Yearly Revenue VS EstimatesABSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
ABSI Yearly EPS VS EstimatesABSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 -1 -1.5 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ABSI. In the last year negative earnings were reported.
Also next year ABSI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABSI Price Earnings VS Forward Price EarningsABSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABSI Per share dataABSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.08%
EPS Next 3Y11.19%

More info and screens

0

5. Dividend

5.1 Amount

ABSI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

ABSCI CORP

NASDAQ:ABSI (12/24/2025, 8:12:10 PM)

After market: 3.57 +0.01 (+0.28%)

3.56

+0.04 (+1.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-16 2026-03-16/amc
Inst Owners66.03%
Inst Owner Change6.7%
Ins Owners6.23%
Ins Owner Change0.62%
Market Cap535.32M
Revenue(TTM)2.81M
Net Income(TTM)-114.60M
Analysts82.67
Price Target8.28 (132.58%)
Short Float %23.76%
Short Ratio6.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.81%
Min EPS beat(2)-10.99%
Max EPS beat(2)7.37%
EPS beat(4)2
Avg EPS beat(4)1.03%
Min EPS beat(4)-10.99%
Max EPS beat(4)10.49%
EPS beat(8)2
Avg EPS beat(8)-2.82%
EPS beat(12)3
Avg EPS beat(12)-7.95%
EPS beat(16)3
Avg EPS beat(16)-8%
Revenue beat(2)0
Avg Revenue beat(2)-66.07%
Min Revenue beat(2)-77.45%
Max Revenue beat(2)-54.7%
Revenue beat(4)0
Avg Revenue beat(4)-51.89%
Min Revenue beat(4)-77.45%
Max Revenue beat(4)-12.08%
Revenue beat(8)0
Avg Revenue beat(8)-46.62%
Revenue beat(12)1
Avg Revenue beat(12)-43.85%
Revenue beat(16)2
Avg Revenue beat(16)-38.63%
PT rev (1m)6.3%
PT rev (3m)-0.16%
EPS NQ rev (1m)0.36%
EPS NQ rev (3m)0.87%
EPS NY rev (1m)2.85%
EPS NY rev (3m)0.1%
Revenue NQ rev (1m)-10.67%
Revenue NQ rev (3m)-29.96%
Revenue NY rev (1m)-20.98%
Revenue NY rev (3m)-21.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 190.17
P/FCF N/A
P/OCF N/A
P/B 2.55
P/tB 3.19
EV/EBITDA N/A
EPS(TTM)-0.9
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.02
BVpS1.4
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -46.78%
ROE -54.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-43.94%
ROA(5y)-42.38%
ROE(3y)-52.85%
ROE(5y)-52.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.15%
Cap/Sales 43.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.89
Quick Ratio 5.89
Altman-Z 4.99
F-Score3
WACC8.8%
ROIC/WACCN/A
Cap/Depr(3y)44.41%
Cap/Depr(5y)179.67%
Cap/Sales(3y)101.78%
Cap/Sales(5y)229.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.67%
EPS Next Y8.18%
EPS Next 2Y11.08%
EPS Next 3Y11.19%
EPS Next 5Y17.17%
Revenue 1Y (TTM)-33.09%
Revenue growth 3Y-1.75%
Revenue growth 5Y17.09%
Sales Q2Q%-77.78%
Revenue Next Year-18.65%
Revenue Next 2Y109.16%
Revenue Next 3Y87.68%
Revenue Next 5Y71.98%
EBIT growth 1Y-15.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1.19%
EBIT Next 3Y-1.31%
EBIT Next 5Y-3.11%
FCF growth 1Y-17.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.2%
OCF growth 3YN/A
OCF growth 5YN/A

ABSCI CORP / ABSI FAQ

What is the ChartMill fundamental rating of ABSCI CORP (ABSI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ABSI.


What is the valuation status for ABSI stock?

ChartMill assigns a valuation rating of 0 / 10 to ABSCI CORP (ABSI). This can be considered as Overvalued.


How profitable is ABSCI CORP (ABSI) stock?

ABSCI CORP (ABSI) has a profitability rating of 1 / 10.


What is the expected EPS growth for ABSCI CORP (ABSI) stock?

The Earnings per Share (EPS) of ABSCI CORP (ABSI) is expected to grow by 8.18% in the next year.